On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Marathon Oil Corp (NYSE: MRO) because he likes the oils. But he recommended not getting greedy.
According to Benzinga Pro, during Q3, Lumentum Holdings (NASDAQ:LITE) earned $26.00 million, a 54.14% increase from the preceding quarter. Lumentum Holdings's sales decreased to $395.40 million, a 11.48% change since Q2.
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Over the past 3 months, 9 analysts have published their opinion on Lumentum Holdings (NASDAQ:LITE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.